查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1980620

介入性心臟病医疗设备市场：规模、份额、成长率和全球产业分析（按类型和应用）、区域洞察以及2026-2034年预测

Interventional Cardiology Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 163 Pages | 商品交期: 请询问到货日

价格

介入性心臟病设备市场的成长要素

全球介入性心臟病设备市场预计到 2025 年将达到 178.6 亿美元，从 2026 年的 191.2 亿美元成长到 2034 年的 340.1 亿美元，2026 年至 2034 年的复合年增长率为 7.50%。北美在 2025 年占据全球市场的主导地位，市场份额为 33.90%，这主要得益于冠状动脉疾病发病率的上升、有利的报销方案以及持续的产品创新。

介入性心臟病学器械是用于微创手术治疗冠状动脉疾病（CAD）、结构性心臟疾病和其他心血管疾病的专用仪器。冠状动脉支架、血管成形术用气球、切割球囊导管和经皮冠状动脉成形术（PTCA）系统等器械在医院和心臟导管检查室中广泛使用。

根据世界卫生组织（世卫组织）的数据，心血管疾病是全球首要死因，每年约造成1,790万人死亡。此外，美国疾病管制与预防中心（CDC）报告称，2020年约有2010万美国成年人患有冠状动脉疾病。日益加重的疾病负担持续推动对先进介入性心臟病学设备的需求。

新冠疫情的影响

2020年，新冠疫情导致择期心血管手术延期，对市场造成了负面影响。医院优先治疗新冠患者，导致冠状动脉疾病和结构性心臟疾病的治疗延误。然而，2021年，全球范围内择期手术和介入治疗逐渐恢復，市场显着復苏。疫情后，由于微创介入治疗住院时间短、恢復快、感染控制措施更严格，医疗专业人员越来越倾向于选择此类治疗，这为市场的长期成长提供了支撑。

市场趋势

向微创手术的转变

微创心臟治疗越来越受欢迎，这是主要趋势之一。这些治疗方法併发症更少、住院时间更短、切口更小，患者康復速度更快。

根据美国心臟协会统计，全球每年约进行150万例心血管手术。光是在美国，每年就约进行90万例经皮冠状动脉介入治疗（PCI）。

保险覆盖范围的扩大进一步加速了这些手术的普及。 2020年，美国医疗保险和医疗补助服务中心（CMS）宣布，在门诊手术中心（ASC）和门诊检查室（OBL）进行的经皮冠状动脉介入治疗（PCI）手术将纳入保险覆盖范围，从而增加了在非医院机构进行的手术数量。

市场成长要素

心血管疾病负担加重

污染、吸烟、饮酒、久坐不动的生活方式和不健康的饮食等环境风险因素的增加，正在导致全球心血管疾病发病率的上升。根据美国心臟学会（ACC）统计，亚洲心血管疾病相关死亡人数从1990年的560万增加到2019年的1080万人。

产品发布及策略合作

主要企业正积极投资研发，并将创新医疗设备推向市场，以满足日益增长的市场需求。例如，2021年7月，Medtronic在欧洲推出了用于经皮冠状动脉介入治疗（PCI）的Prevail药物释放型球囊（DCB）导管。同样，各公司也积极寻求合作、收购和监管核准，以增强产品系列。

抑制因子

儘管成长前景强劲，但产品召回和监管仍然是挑战。 2023年7月，雅培公司宣布召回用于左心耳封堵术的心臟导管，原因是安全隐患。此外，血肿、血管损伤和桡动脉闭塞等併发症可能会阻碍此类器械的广泛应用。严格的监管核准流程也会延缓新产品的上市。

細項分析

副产品

市场区隔包括冠状动脉支架、结构性心臟疾病器械、血管成形术用气球、栓塞预防器械等。

  • 预计到 2025 年，冠状动脉支架将占据市场主导地位，市场份额达到 38.55%，这主要得益于中国等国家较高的手术量以及政府主导的采购计划。
  • 由于经导管主动脉瓣置换术)的数量不断增加，预计结构性心臟装置的年复合成长率将会更高。
  • 预计用于血管生成的球囊领域也将迎来显着成长。

最终用户

  • 到 2026 年，医院和门诊手术中心 (ASC) 将占市场份额的 66.21%，这主要得益于住院患者数量和手术量的增加。
  • 随着全球基础设施的扩张，导管介入检查室及相关领域预计将经历适度成长。

区域趋势

北美洲

预计到2025年，北美市场规模将达到60.5亿美元，其持续成长的动力来自于优惠的还款方案和技术进步。美国市场预计到2026年将达到61.8亿美元。

欧洲

欧洲占了相当大的市场份额，这主要得益于价格适中的医疗设备和不断增加的监管核准。预计到2026年，英国市场规模将达到6.8亿美元，德国市场规模预计将达到15.2亿美元。

亚太地区

受患者人数成长和国内製造业发展推动，亚太地区预计在2025年至2034年间实现最高的复合年增长率。预计2026年，中国市场规模将达9.8亿美元，日本4.7亿美元，印度7.9亿美元。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 2023/2025年主要国家/地区心血管疾病盛行率
  • 2023/2025年主要国家/地区心房颤动发生率
  • 流行病学：主要国家/地区2023/2025年卒中状况
  • 2023/2025年主要国家经皮皮冠状动脉介入治疗（PCI）数量
  • 新产品发布：按主要企业划分
  • 产业重大发展动态－併购与合作
  • 新冠疫情对市场的影响

第五章：2021-2034年全球介入性心臟病医疗设备市场分析、洞察与预测

  • 市场分析、洞察与预测：按产品划分。
    • 冠状动脉支架
      • 裸金属支架（BMS）
      • 药物释放型支架（DES）
      • 其他的
    • 结构性心臟疾病治疗装置
      • 心臟瓣膜
      • 闭塞装置及其他
    • 用于血管生成的球囊
    • 导管
      • 诊断导管
      • 治疗性导管
    • 栓塞预防装置
    • 其他的
  • 市场分析、洞察与预测：按最终用户划分
    • 医院及日间手术中心
    • 导管检查室及其他
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美介入性心臟病医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲介入性心臟病医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 英国
    • 其他欧洲国家

第八章：亚太地区介入性心臟病医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 东南亚
    • 其他亚太国家

第九章：拉丁美洲介入性心臟病医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 墨西哥
    • 巴西
    • 其他拉丁美洲国家

第十章：中东和非洲介入性心臟病医疗设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • GCC
    • 南非
    • 其他中东和非洲国家

第十一章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • Boston Scientific Corporation
    • Abbott
    • Medtronic
    • BIOTRONIK SE & Co. KG
    • iVascular
    • Terumo Corporation
    • Teleflex Incorporated
    • B. Braun SE
    • Alvimedica
    • Biosensors International Group, Ltd
Product Code: FBI107414

Growth Factors of interventional cardiology devices Market

The global interventional cardiology devices market was valued at USD 17.86 billion in 2025 and is projected to grow from USD 19.12 billion in 2026 to USD 34.01 billion by 2034, registering a CAGR of 7.50% during 2026-2034. North America dominated the global market with a 33.90% share in 2025, driven by the rising incidence of coronary heart diseases, favorable reimbursement frameworks, and continuous product innovations.

Interventional cardiology devices are specialized tools used in minimally invasive procedures to treat coronary artery disease (CAD), structural heart disorders, and other cardiovascular conditions. Devices such as coronary stents, angioplasty balloons, cutting balloon catheters, and Percutaneous Transluminal Coronary Angioplasty (PTCA) systems are widely used across hospitals and cardiac catheterization laboratories.

According to the World Health Organization, cardiovascular diseases (CVDs) account for approximately 17.9 million deaths globally each year, making them the leading cause of mortality worldwide. Additionally, the Centers for Disease Control and Prevention reported that around 20.1 million U.S. adults suffered from coronary artery disease in 2020. This increasing disease burden continues to fuel demand for advanced interventional cardiology devices.

COVID-19 Impact

The COVID-19 pandemic negatively impacted the market in 2020 due to postponement of elective cardiac procedures. Hospitals prioritized COVID-19 cases, delaying coronary and structural heart treatments. However, substantial recovery was observed in 2021 as elective and interventional procedures resumed globally. Post-pandemic, healthcare professionals increasingly prefer minimally invasive interventional procedures due to shorter hospital stays, faster recovery, and better infection control, supporting long-term market expansion.

Market Trends

Shifting Preference Toward Minimally Invasive Procedures

The growing preference for minimally invasive cardiac procedures is a key trend. These procedures offer reduced complications, shorter hospital stays, minimal incisions, and faster patient recovery.

According to the American Heart Association, approximately 1.5 million cardiac surgeries are performed globally each year. In the U.S. alone, nearly 900,000 Percutaneous Coronary Interventions (PCIs) are performed annually.

Reimbursement expansion has further strengthened adoption. In 2020, the Centers for Medicare & Medicaid Services announced reimbursement coverage for PCI procedures in Ambulatory Surgical Centers (ASCs) and Office-Based Labs (OBLs), accelerating procedural volumes outside hospital settings.

Market Growth Drivers

Rising Cardiovascular Disease Burden

Increasing environmental risk factors such as pollution, smoking, alcohol consumption, sedentary lifestyles, and unhealthy diets are contributing to the global rise in cardiovascular diseases. According to the American College of Cardiology, cardiovascular-related deaths in Asia increased from 5.6 million in 1990 to 10.8 million in 2019.

Product Launches and Strategic Collaborations

Major players are actively investing in R&D and launching innovative devices to meet growing demand. For instance, in July 2021, Medtronic launched the Prevail Drug-Coated Balloon (DCB) catheter in Europe for PCI procedures. Similarly, companies are engaging in partnerships, acquisitions, and regulatory approvals to strengthen product portfolios across emerging economies such as China and India.

Restraining Factors

Despite strong growth prospects, product recalls and regulatory scrutiny pose challenges. In July 2023, Abbott issued a recall for a cardiac catheter used in left atrial appendage occlusion due to safety concerns. Additionally, complications such as hematoma, vascular injury, and radial artery occlusion may limit device adoption. Strict regulatory approval processes also slow new product commercialization.

Segmentation Analysis

By Product

The market is segmented into coronary stents, structural heart devices, angioplasty balloons, catheters, embolic protection devices, and others.

  • Coronary stents dominated the market with a 38.55% share in 2025, driven by high procedural volumes and government-led procurement programs in countries like China.
  • Structural heart devices are projected to grow at a higher CAGR due to rising Transcatheter Aortic Valve Replacement (TAVR) procedures.
  • Angioplasty balloons are also expected to witness substantial growth.

By End User

  • Hospitals & Ambulatory Surgical Centers (ASCs) accounted for 66.21% share in 2026, owing to rising hospital admissions and procedure volumes.
  • Catheterization labs & others are projected to grow moderately with expanding infrastructure globally.

Regional Insights

North America

North America generated USD 6.05 billion in 2025 and continues to dominate due to strong reimbursement policies and technological advancements. The U.S. market is projected to reach USD 6.18 billion by 2026.

Europe

Europe holds a significant share driven by affordable device pricing and rising regulatory approvals. The UK market is projected to reach USD 0.68 billion by 2026, while Germany is expected to reach USD 1.52 billion by 2026.

Asia Pacific

Asia Pacific is projected to register the highest CAGR during 2025-2034 due to expanding patient pools and domestic manufacturing growth. China is projected to reach USD 0.98 billion by 2026, Japan USD 0.47 billion, and India USD 0.79 billion.

Competitive Landscape

Prominent companies operating in the market include Edwards Lifesciences, Boston Scientific Corporation, Abbott, Medtronic, BIOTRONIK SE & Co. KG, Terumo Corporation, and B. Braun SE. These companies are focusing on product innovation, acquisitions, regulatory approvals, and geographic expansion to strengthen their global footprint.

Conclusion

The global interventional cardiology devices market is set for robust growth from USD 17.86 billion in 2025 to USD 34.01 billion by 2034, supported by the rising burden of cardiovascular diseases, increasing preference for minimally invasive procedures, expanding reimbursement coverage, and continuous technological advancements. While product recalls and regulatory challenges may restrain short-term growth, sustained innovation, strategic partnerships, and expanding healthcare infrastructure-especially in Asia Pacific-will ensure strong long-term market expansion through 2034.

Unit CAGR of 7.50% from 2026-2034

Segmentation By Product

  • Coronary Stents
    • Bare-metal Stent (BMS)
    • Drug-eluting Stent (DES)
    • Others
  • Structural Heart Devices
    • Heart Valves
    • Occluders & Others
  • Angioplasty Balloons
  • Catheters
    • Diagnostic Catheters
  • Angiography
  • IVUS
  • Others
    • Treatment Catheters
  • Atherectomy
  • Thrombectomy
  • Ablation
  • Others
  • Embolic Protection Devices
  • Others

By End User

  • Hospitals & ASCs
  • Catheterization Labs & Others

By Region

  • North America (By Product, End User, and Country)
    • U.S.
    • Canada
  • Europe (By Product, End User, and Country/Sub-region)
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Product, End User, and Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, End User, and Country/Sub-region)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (By Product, End User, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Cardiovascular Diseases, By Key Countries/ Region, 2023/2025
  • 4.2. Incidence of Atrial Fibrillation, By Key Countries/ Region, 2023/2025
  • 4.3. Epidemiology: Stroke, By Key Countries/ Region, 2023/2025
  • 4.4. Number of Percutaneous Coronary Interventions Procedures, By Key Countries, 2023/2025
  • 4.5. New Product Launches, By Key Players
  • 4.6. Key Industry Developments - Mergers, Acquisition, and Partnerships
  • 4.7. Impact of COVID-19 on the Market

5. Global Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Coronary Stents
      • 5.1.1.1. Bare-metal Stent (BMS)
      • 5.1.1.2. Drug-eluting Stent (DES)
      • 5.1.1.3. Others
    • 5.1.2. Structural Heart Devices
      • 5.1.2.1. Heart Valves
      • 5.1.2.2. Occluders & Others
    • 5.1.3. Angioplasty Balloons
    • 5.1.4. Catheters
      • 5.1.4.1. Diagnostic Catheters
        • 5.1.4.1.1. Angiography
        • 5.1.4.1.2. IVUS
        • 5.1.4.1.3. Others
      • 5.1.4.2. Treatment Catheters
        • 5.1.4.2.1. Atherectomy
        • 5.1.4.2.2. Thrombectomy
        • 5.1.4.2.3. Ablation
        • 5.1.4.2.4. Others
    • 5.1.5. Embolic Protection Devices
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & ASCs
    • 5.2.2. Catheterization Labs & Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East and Africa

6. North America Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Coronary Stents
      • 6.1.1.1. Bare-metal Stent (BMS)
      • 6.1.1.2. Drug-eluting Stent (DES)
      • 6.1.1.3. Others
    • 6.1.2. Structural Heart Devices
      • 6.1.2.1. Heart Valves
      • 6.1.2.2. Occluders & Others
    • 6.1.3. Angioplasty Balloons
    • 6.1.4. Catheters
      • 6.1.4.1. Diagnostic Catheters
        • 6.1.4.1.1. Angiography
        • 6.1.4.1.2. IVUS
        • 6.1.4.1.3. Others
      • 6.1.4.2. Treatment Catheters
        • 6.1.4.2.1. Atherectomy
        • 6.1.4.2.2. Thrombectomy
        • 6.1.4.2.3. Ablation
        • 6.1.4.2.4. Others
    • 6.1.5. Embolic Protection Devices
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By End User
    • 6.2.1. Hospitals & ASCs
    • 6.2.2. Catheterization Labs & Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Coronary Stents
      • 7.1.1.1. Bare-metal Stent (BMS)
      • 7.1.1.2. Drug-eluting Stent (DES)
      • 7.1.1.3. Others
    • 7.1.2. Structural Heart Devices
      • 7.1.2.1. Heart Valves
      • 7.1.2.2. Occluders & Others
    • 7.1.3. Angioplasty Balloons
    • 7.1.4. Catheters
      • 7.1.4.1. Diagnostic Catheters
        • 7.1.4.1.1. Angiography
        • 7.1.4.1.2. IVUS
        • 7.1.4.1.3. Others
      • 7.1.4.2. Treatment Catheters
        • 7.1.4.2.1. Atherectomy
        • 7.1.4.2.2. Thrombectomy
        • 7.1.4.2.3. Ablation
        • 7.1.4.2.4. Others
    • 7.1.5. Embolic Protection Devices
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By End User
    • 7.2.1. Hospitals & ASCs
    • 7.2.2. Catheterization Labs & Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. Germany
    • 7.3.2. Spain
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. U.K.
    • 7.3.6. Rest of Europe

8. Asia Pacific Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Coronary Stents
      • 8.1.1.1. Bare-metal Stent (BMS)
      • 8.1.1.2. Drug-eluting Stent (DES)
      • 8.1.1.3. Others
    • 8.1.2. Structural Heart Devices
      • 8.1.2.1. Heart Valves
      • 8.1.2.2. Occluders & Others
    • 8.1.3. Angioplasty Balloons
    • 8.1.4. Catheters
      • 8.1.4.1. Diagnostic Catheters
        • 8.1.4.1.1. Angiography
        • 8.1.4.1.2. IVUS
        • 8.1.4.1.3. Others
      • 8.1.4.2. Treatment Catheters
        • 8.1.4.2.1. Atherectomy
        • 8.1.4.2.2. Thrombectomy
        • 8.1.4.2.3. Ablation
        • 8.1.4.2.4. Others
    • 8.1.5. Embolic Protection Devices
    • 8.1.6. Others
  • 8.2. Market Analysis, Insights and Forecast - By End User
    • 8.2.1. Hospitals & ASCs
    • 8.2.2. Catheterization Labs & Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. China
    • 8.3.2. India
    • 8.3.3. Japan
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Coronary Stents
      • 9.1.1.1. Bare-metal Stent (BMS)
      • 9.1.1.2. Drug-eluting Stent (DES)
      • 9.1.1.3. Others
    • 9.1.2. Structural Heart Devices
      • 9.1.2.1. Heart Valves
      • 9.1.2.2. Occluders & Others
    • 9.1.3. Angioplasty Balloons
    • 9.1.4. Catheters
      • 9.1.4.1. Diagnostic Catheters
        • 9.1.4.1.1. Angiography
        • 9.1.4.1.2. IVUS
        • 9.1.4.1.3. Others
      • 9.1.4.2. Treatment Catheters
        • 9.1.4.2.1. Atherectomy
        • 9.1.4.2.2. Thrombectomy
        • 9.1.4.2.3. Ablation
        • 9.1.4.2.4. Others
    • 9.1.5. Embolic Protection Devices
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By End User
    • 9.2.1. Hospitals & ASCs
    • 9.2.2. Catheterization Labs & Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Mexico
    • 9.3.2. Brazil
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Interventional Cardiology Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Coronary Stents
      • 10.1.1.1. Bare-metal Stent (BMS)
      • 10.1.1.2. Drug-eluting Stent (DES)
      • 10.1.1.3. Others
    • 10.1.2. Structural Heart Devices
      • 10.1.2.1. Heart Valves
      • 10.1.2.2. Occluders & Others
    • 10.1.3. Angioplasty Balloons
    • 10.1.4. Catheters
      • 10.1.4.1. Diagnostic Catheters
        • 10.1.4.1.1. Angiography
        • 10.1.4.1.2. IVUS
        • 10.1.4.1.3. Others
      • 10.1.4.2. Treatment Catheters
        • 10.1.4.2.1. Atherectomy
        • 10.1.4.2.2. Thrombectomy
        • 10.1.4.2.3. Ablation
        • 10.1.4.2.4. Others
    • 10.1.5. Embolic Protection Devices
    • 10.1.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By End User
    • 10.2.1. Hospitals & ASCs
    • 10.2.2. Catheterization Labs & Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Abbott
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Medtronic
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. BIOTRONIK SE & Co. KG
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. iVascular
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Terumo Corporation
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Teleflex Incorporated
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. B. Braun SE
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Alvimedica
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Biosensors International Group, Ltd
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 02: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 03: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 04: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 05: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 06: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 07: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 08: Global Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 09: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 10: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 11: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 12: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 13: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 14: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 15: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 16: North America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 17: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 18: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 19: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 20: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 21: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 22: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 23: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 24: Europe Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 26: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 27: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 28: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 29: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 30: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 31: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 33: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 34: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 35: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 36: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 37: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 38: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 39: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 40: Latin America Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 42: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Coronary Stents, 2021-2034
  • Table 43: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Structural Heart Devices, 2021-2034
  • Table 44: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Catheters, 2021-2034
  • Table 45: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Diagnostic Catheters, 2021-2034
  • Table 46: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Treatment Catheters, 2021-2034
  • Table 47: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 48: Middle East & Africa Interventional Cardiology Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Interventional Cardiology Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global Interventional Cardiology Devices Market Value Share (%), By Product, 2025 & 2034
  • Figure 03: Global Interventional Cardiology Devices Market Value Share (%), By End User, 2025 & 2034
  • Figure 04: Global Interventional Cardiology Devices Market Value Share (%), By Region, 2025 & 2034
  • Figure 05: North America Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 06: North America Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 07: North America Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 08: North America Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 09: North America Interventional Cardiology Devices Market Value (USD billion), by Country, 2025 & 2034
  • Figure 10: North America Interventional Cardiology Devices Market Value Share (%), by Country, 2025
  • Figure 11: Europe Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 12: Europe Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 13: Europe Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: Europe Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 15: Europe Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Asia Pacific Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 19: Asia Pacific Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 20: Asia Pacific Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 21: Asia Pacific Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 23: Latin America Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 24: Latin America Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 25: Latin America Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 26: Latin America Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 27: Latin America Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Interventional Cardiology Devices Market Value (USD billion), by Product, 2025 & 2034
  • Figure 30: Middle East & Africa Interventional Cardiology Devices Market Value Share (%), by Product, 2025
  • Figure 31: Middle East & Africa Interventional Cardiology Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 32: Middle East & Africa Interventional Cardiology Devices Market Value Share (%), by End User, 2025
  • Figure 33: Middle East & Africa Interventional Cardiology Devices Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Interventional Cardiology Devices Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 35: Global Interventional Cardiology Devices Market Share (%), By Company, 2025